[1]
Nandi, S. and Bagchi, M.C. 2022. Exploring CDKs, Ras-ERK, and PI3K-Akt in Abnormal Signaling and Cancer. Journal of Cancer Research Updates. 11, (Oct. 2022), 63–69. DOI:https://doi.org/10.30683/1929-2279.2022.11.09.